XML 43 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Debt - Additional Information (Details)
3 Months Ended 9 Months Ended
Sep. 24, 2019
$ / shares
Sep. 23, 2019
USD ($)
$ / shares
Aug. 29, 2019
USD ($)
shares
Jun. 10, 2019
USD ($)
Nov. 30, 2018
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Debt Instrument [Line Items]                    
Gross proceeds from issuance of equity securities                 $ 19,803,000  
Proceeds from issuance of convertible note                 2,600,000  
Convertible debt converted into shares of common stock | shares     2,267,042              
Gain on debt extinguishment     $ 900,000       $ 928,000   928,000  
2018 Convertible Bridge Notes                    
Debt Instrument [Line Items]                    
Convertible note, principal amount         $ 6,800,000          
Proceeds from issuance of convertible note         $ 6,600,000          
Debt instrument, interest rate         10.00%          
Debt maturity date         Mar. 31, 2019          
Increase in interest rate if bridge notes not paid or converted               15.00%    
Percentage of multiplier on price per share of new stock paid in qualified financing by investors               70.00%    
Denominator for calculating capitalization value for price per share           $ 45,000,000   $ 45,000,000    
Debt discount           2,500,000   $ 2,500,000    
Maturity date, description               As part of the amendment, the maturity dates of the notes were extended to the earliest of (i) September 24, 2019; (ii) the occurrence of an Event of Default (as defined in the 2018 Bridge Notes); (iii) the consummation of a liquidation or dissolution of DermTech Operations; (iv) a Liquidation Transaction (as defined in the 2018 Bridge Notes); or (v) the consummation of a merger with or into the Company or any of its subsidiaries.    
Convertible notes conversion ratio   0.70                
Description of merger consideration               “Merger Consideration” means (i) the lesser of $6.46 and (ii) the offering price per share of the private investment in public equity transaction to be consummated concurrently with the consummation of the Qualifying Merger (the “2019 PIPE Financing”) multiplied by the Conversion Ratio.    
Merger consideration maximum price per share | $ / shares   $ 6.46                
Debt Conversion Ratio Number Used As Numerator to Derive Quotient   $ 8,000,000                
Liability balance           0   $ 0   $ 0
2018 Convertible Bridge Notes | Other Expense                    
Debt Instrument [Line Items]                    
Loss on change in fair value of derivative liability           0 100,000 0 400,000  
2018 Convertible Bridge Notes | Minimum                    
Debt Instrument [Line Items]                    
Gross proceeds from issuance of equity securities               20,000,000    
2019 Convertible Bridge Notes                    
Debt Instrument [Line Items]                    
Debt instrument, interest rate       10.00%            
Debt discount           300,000   $ 300,000    
Maturity date, description               These convertible bridge notes carried an interest rate of 10% and matured after the earliest to occur of: (i) September 25, 2019; (ii) the occurrence of an Event of Default (as defined in the 2019 Bridge Notes); (iii) the consummation of a liquidation or dissolution of DermTech Operations; (iv) a Liquidation Transaction (as defined in the 2019 Bridge Notes); or (v) the consummation of a merger of DermTech Operations with DT Merger Sub, Inc., a previous subsidiary of the Company, in accordance with the Merger Agreement.    
Debt Conversion Ratio Number Used As Numerator to Derive Quotient   $ 8,000,000                
Proceeds from issuance of convertible note       $ 2,600,000            
Debt conversion feature               Upon the conversion of these notes, the note holders were entitled to receive a number of shares of DermTech Operations’ common stock equal to the quotient obtained by dividing (i) the unpaid principal amount of these notes plus interest accrued but unpaid thereon, by (1) if the Qualifying Merger consummates prior to the maturity date, the lesser of (x) $5.80 and (y) 90% of the Merger Consideration (as defined below), or (2) if the Qualifying Merger consummates on or after the maturity date, the lesser of (x) $4.51 and (y) 70% of the Merger Consideration.    
Liability balance           0   $ 0   $ 0
2019 Convertible Bridge Notes | Other Expense                    
Debt Instrument [Line Items]                    
Loss on change in fair value of derivative liability           $ 0 $ 11,000 $ 0 $ 14,000  
2019 Convertible Bridge Notes | Maximum                    
Debt Instrument [Line Items]                    
Convertible notes conversion ratio 0.70 0.90                
Convertible notes conversion price | $ / shares $ 4.51 $ 5.80